Dr. Kenneth Kam is the International Marketing Director at Xcelom, a leader in non-invasive prenatal testing (NIPT) and genetic diagnostics. With a PhD in molecular biology from HKU, he previously served as Vice President at BGI, driving global market expansion in genetic testing. An award-winning expert in genomics, Dr. Kam has contributed to 14 peer-reviewed publications and multiple patents. His current focus is on the clinical application of long-read sequencing, leading Xcelom’s efforts in technology transfer to empower laboratories worldwide to perform clinical tests using this cutting-edge technology. He actively supports scientific innovation through various advisory and leadership roles.